Kohlberg Kravis Roberts & Co. L.P. has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $2.37 Billion distributed in 70 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Bridge Bio Pharma, Inc. with a value of $960M, Bright View Holdings, Inc. with a value of $603M, Property Guru Group LTD with a value of $165M, Transphorm, Inc. with a value of $120M, and Endeavor Group Holdings, Inc. with a value of $116M.
Examining the 13F form we can see an decrease of $470M in the current position value, from $2.84B to 2.37B.
Kohlberg Kravis Roberts & Co. L.P. is based out at New York, NY
Below you can find more details about Kohlberg Kravis Roberts & Co. L.P. portfolio as well as his latest detailed transactions.